Airway Shield Analysis

Facilitate safer intubation procedures in hospitals; Reduce infection risk during intubation; Protect patients from dental trauma; Decrease intubation time significantly; Enable use by less trained staff in emergencies.

CE Mark obtained in 2022; FDA designation as "Safer Technology"; International patent filed for the device.

Main Information

• Information: Airway Shield SL has developed the first device in the world that facilitates endotracheal intubation through an easy, fast, and safe procedure, reducing complications associated with this procedure. The device protects patients and healthcare professionals, with advantages including guided intubation, protection of the oral mucosa and teeth, and reduced exposure to pathogens for healthcare professionals.
• Interests: HEALTH/FITNESS/WELLBEING
• Location: Hall 8.1 - 4YFN Stand 8.1A50
• Tagged as startup: Yes

Contact & Links

• LinkedIn: Not available
• Twitter: Not available
• Phone Number: Not available
• Email: Not available

Key Information

• Growth Stage: Series A
• Country: Spain
• Founding Year: 2020

Company Context

• Company Name: Airway Shield
• Company Website: https://airwayshield.com/